Nov 16, 2018
| USA, News
Benchside TCR therapy insights! Review the interview with Amir Alpert (Senior Scientist) about "Harnessing the Power of the Immune Systeme: Optimizing T Cell Killing Cancer Immunotherapy" in "Select Science".
Review the full article here.
Immatics Biotechnologies GmbH
+49 89 540 415 606
Always up to date: Receive posts from us and our partners via our Twitter profile.
Find out more about Immatics on LinkedIn with our News, Events & Press Releases.
Follow us on Xing: Receive corporate updates around our technologies and collaborations.